Subscribe to RSS
DOI: 10.1055/s-0041-111803
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a
Beidseitige periphere Teleangiektasien bei Interferon-B1a-behandelten Multiple-Sklerose-PatientenPublication History
Publication Date:
26 April 2016 (online)
![](https://www.thieme-connect.de/media/klimo/201604/lookinside/thumbnails/10-1055-s-0041-111803_klt499-1.jpg)
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by myelin and oligodendrocytes damage, local gliosis and axonal injury. Ophthalmic manifestations include lesions of either the neuro-ophtalmic afferent visual pathway, the efferent oculomotor pathways, or the eye with anterior, intermediate or posterior uveitis [1]. The most common mode of presentation of MS is a relapsing remitting course [2], commonly treated with immunomodulatory agents, such as subcutaneous interferon beta1a injection (IB1a). The systemic use of IB1a can rarely be complicated by ischemic retinopathy accompanied by retinal hemorrhages, cotton wool spots and microvascular retinal occlusions affecting mostly the posterior pole [3], [4], [5]. All the above publications reported the disappearance of the retinal manifestations with the discontinuation of IB1a therapy. Clinical presentation of IB1a retinopathy is compared to the ischemic retinopathy associated with interferon alpha [6] and both molecules are structurally related and share a common ancestor [7]. We describe the ophthalmic features of two patients diagnosed with quiescent relapsing-remitting MS previously treated with IB1a who both exhibited asymptomatic bilateral peripheral retinal telangiectasiae.
-
References
- 1 Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004; 12: 137-142
- 2 Katz Sand I. Classification, diagnosis and differential diagnosis of multiple sclerosis. Curr Opin Neurol 2015; 28: 193-205
- 3 Longmuir R, Lee AG, Rouleau J. Cotton wool spots associated with interferon beta-1 alpha therapy. Semin Ophthalmol 2007; 22: 49-53
- 4 Saito H, Suzuki M, Asakawa T et al. Retinopathy in a multiple sclerosis patient undergoing interferon-therapy. Mult Scler 2007; 13: 939-940
- 5 Bakri SJ, Swanson JW. Asymptomatic Peripheral Retinal Hemorrhages as a Manifestation of Interferon Beta 1a Retinopathy. Semin Ophthalmol 2015; 30: 56-57
- 6 Guyer DR, Tiedeman J, Yannuzzi LA et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-356
- 7 Taniguchi T, Mantei N, Schwarzstein M. Human leukocyte and fibroblast interferons are structurally related. Nature 1980; 285: 547-549
- 8 Querques G, Bux AV. Leber miliary aneurysms and multiple sclerosis. Eur J Ophthalmol 2009; 19: 690-693
- 9 Ortiz-Perez S, Martinez-Lapiscina EH, Gabilondo I et al. Retinal periphlebitis is associated with multiple sclerosis severity. Neurology 2013; 81: 877-881
- 10 Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994; 14: 445-451